CenturyDX is a next-generation biotechnology and diagnostic solutions company focused on advancing healthcare through cutting-edge molecular diagnostics, genomics, and personalized medicine. Based in the UAE, CenturyDX offers a full suite of diagnostic testing services, laboratory solutions, and clinical decision support tools that help healthcare providers make faster, more accurate diagnoses. The company utilizes advanced technologies such as PCR, NGS (Next-Generation Sequencing), and AI-powered analytics to deliver actionable insights for conditions ranging from infectious diseases to genetic disorders and oncology. CenturyDX’s solutions are designed to meet the stringent regulatory and quality requirements of modern healthcare systems, including CLIA and CAP standards. With a mission to make high-quality diagnostics accessible and affordable, CenturyDX partners with hospitals, research labs, and public health authorities to improve patient outcomes and streamline clinical workflows. Their R&D efforts are also focused on developing point-of-care testing devices and mobile health platforms that bring precision diagnostics closer to the patient. In an era of personalized healthcare, CenturyDX is setting the benchmark for diagnostic innovation in the MENA region.